4/28
06:45 am
acrs
Form 8-K Aclaris Therapeutics, For: Apr 28
High
Report
Form 8-K Aclaris Therapeutics, For: Apr 28
4/27
07:27 pm
acrs
Form 4 Aclaris Therapeutics, For: Apr 27 Filed by: Leonard Braden Michael
Medium
Report
Form 4 Aclaris Therapeutics, For: Apr 27 Filed by: Leonard Braden Michael
4/27
07:26 pm
acrs
Form SCHEDULE 13G/A Aclaris Therapeutics, Filed by: BML Investment Partners, L.P.
Medium
Report
Form SCHEDULE 13G/A Aclaris Therapeutics, Filed by: BML Investment Partners, L.P.
4/23
07:48 am
acrs
Form ARS Aclaris Therapeutics, For: Dec 31
Medium
Report
Form ARS Aclaris Therapeutics, For: Dec 31
4/23
07:47 am
acrs
Form DEFA14A Aclaris Therapeutics,
Medium
Report
Form DEFA14A Aclaris Therapeutics,
4/23
07:45 am
acrs
Form DEF 14A Aclaris Therapeutics, For: Jun 04
Medium
Report
Form DEF 14A Aclaris Therapeutics, For: Jun 04
4/7
06:00 pm
acrs
Form SCHEDULE 13G Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SCHEDULE 13G Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
3/26
03:06 pm
acrs
Form SCHEDULE 13G/A Aclaris Therapeutics, Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Aclaris Therapeutics, Filed by: VANGUARD GROUP INC
3/17
04:17 pm
acrs
Form SCHEDULE 13G Aclaris Therapeutics, Filed by: Deep Track Capital, LP
Medium
Report
Form SCHEDULE 13G Aclaris Therapeutics, Filed by: Deep Track Capital, LP
3/11
04:31 pm
acrs
Form 8-K Aclaris Therapeutics, For: Mar 10
Medium
Report
Form 8-K Aclaris Therapeutics, For: Mar 10
3/10
06:03 am
acrs
Form 8-K Aclaris Therapeutics, For: Mar 09
Medium
Report
Form 8-K Aclaris Therapeutics, For: Mar 09
3/3
04:15 pm
acrs
Form 4 Aclaris Therapeutics, For: Mar 01 Filed by: Balthaser Kevin
Low
Report
Form 4 Aclaris Therapeutics, For: Mar 01 Filed by: Balthaser Kevin
2/26
04:32 pm
acrs
Form 10-K Aclaris Therapeutics, For: Dec 31
Medium
Report
Form 10-K Aclaris Therapeutics, For: Dec 31
2/26
07:15 am
acrs
Form 8-K Aclaris Therapeutics, For: Feb 26
Low
Report
Form 8-K Aclaris Therapeutics, For: Feb 26
2/9
01:42 pm
acrs
Form SCHEDULE 13G/A Aclaris Therapeutics, Filed by: BML Investment Partners, L.P.
Low
Report
Form SCHEDULE 13G/A Aclaris Therapeutics, Filed by: BML Investment Partners, L.P.
2/6
06:10 pm
acrs
Form 4 Aclaris Therapeutics, For: Feb 02 Filed by: Walker Neal
Low
Report
Form 4 Aclaris Therapeutics, For: Feb 02 Filed by: Walker Neal
2/6
06:08 pm
acrs
Form 4 Aclaris Therapeutics, For: Feb 02 Filed by: Davis Hugh M.
Low
Report
Form 4 Aclaris Therapeutics, For: Feb 02 Filed by: Davis Hugh M.
2/6
06:06 pm
acrs
Form 4 Aclaris Therapeutics, For: Feb 02 Filed by: Kolbeck Roland Wilhelm
Low
Report
Form 4 Aclaris Therapeutics, For: Feb 02 Filed by: Kolbeck Roland Wilhelm
2/6
06:05 pm
acrs
Form 4 Aclaris Therapeutics, For: Feb 02 Filed by: Hall Jesse Wayne
Low
Report
Form 4 Aclaris Therapeutics, For: Feb 02 Filed by: Hall Jesse Wayne
2/6
06:03 pm
acrs
Form 4 Aclaris Therapeutics, For: Feb 02 Filed by: Loerop James
Low
Report
Form 4 Aclaris Therapeutics, For: Feb 02 Filed by: Loerop James
2/6
06:01 pm
acrs
Form 4 Aclaris Therapeutics, For: Feb 02 Filed by: Balthaser Kevin
Low
Report
Form 4 Aclaris Therapeutics, For: Feb 02 Filed by: Balthaser Kevin
2/5
04:49 pm
acrs
Form 4 Aclaris Therapeutics, For: Feb 03 Filed by: Loerop James
Medium
Report
Form 4 Aclaris Therapeutics, For: Feb 03 Filed by: Loerop James
2/5
04:46 pm
acrs
Form 4 Aclaris Therapeutics, For: Feb 03 Filed by: Walker Neal
Medium
Report
Form 4 Aclaris Therapeutics, For: Feb 03 Filed by: Walker Neal
2/5
04:44 pm
acrs
Form 4 Aclaris Therapeutics, For: Feb 03 Filed by: Davis Hugh M.
Medium
Report
Form 4 Aclaris Therapeutics, For: Feb 03 Filed by: Davis Hugh M.
2/5
04:42 pm
acrs
Form 4 Aclaris Therapeutics, For: Feb 03 Filed by: Balthaser Kevin
Medium
Report
Form 4 Aclaris Therapeutics, For: Feb 03 Filed by: Balthaser Kevin